Trump pardons Flynn, taking direct aim at Russia probe
WASHINGTON (AP) — President Donald Trump has pardoned former national security adviser Michael Flynn, taking direct aim in the final days of his administration at a Russia investigation that he has long insisted was motivated by political bias. Trump announced the pardon on Wednesday, calling it his “Great Honor.” Flynn is the second Trump associate…
Read MoreBiden Transition Gets Govt OK after Trump Out of Options
WASHINGTON (AP) — The federal government has recognized President-elect Joe Biden as the “apparent winner” of the Nov. 3 election. That formally starts the transition of power after President Donald Trump has spent weeks testing the boundaries of American democracy. The move came after Trump suffered yet more legal and procedural defeats in his seemingly…
Read MoreMillions stick to Thanksgiving travel plans despite warnings
AP-US-Virus-Outbreak, 2nd Ld-Writethru Nov 23, 2020 12:39PM (GMT 18:39) Despite emphatic warnings from public health authorities to stay home for Thanksgiving, millions of Americans are crowding the nation’s airports ahead of the holiday, many of them unwilling to miss out on seeing family and convinced they can do it safely. More than 3 million people…
Read MoreBiden Expected to Nominate Blinken as Secretary of State
WASHINGTON (AP) — A longtime national security aide to President-elect Joe Biden, Antony Blinken, is expected to become Biden's nominee for secretary of state. Multiple people familiar with the Biden team’s planning tell The Associated Press that Blinken is at the front of his choices to be America's top diplomat. Blinken served as deputy secretary…
Read MoreTrump makes late-term bid to lower prescription drug costs
WASHINGTON (AP) — President Donald Trump's administration is trying to close out major unfinished business on lowering prescription drug costs. Two regulations issued Friday promise savings for Medicare recipients. One would tie payments for drugs administered in a doctor's office to lower prices paid abroad. The second would require that drugmaker rebates for pharmacy medications…
Read More